tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Galderma Group AG (CH:GALD)
:GALD
Switzerland Market
GALD
Galderma Group AG
RESEARCH TOOLSreports

Galderma Group AG (GALD) Stock News & Sentiment

Compare
12 Followers
Galderma Group AG: Buy Rating Reaffirmed with 19% Price Target Increase Amid Strong Nemluvio Growth Projections
Premium
Ratings
Galderma Group AG: Buy Rating Reaffirmed with 19% Price Target Increase Amid Strong Nemluvio Growth Projections
8d ago
Strategic Partnership and Stake Increase Drive Positive Outlook for Galderma: Buy Recommendation
Premium
Ratings
Strategic Partnership and Stake Increase Drive Positive Outlook for Galderma: Buy Recommendation
11d ago
Galderma Group AG: Promising Growth Outlook and Strategic Expansion Drive Buy Rating
Premium
Ratings
Galderma Group AG: Promising Growth Outlook and Strategic Expansion Drive Buy Rating
1M ago
Galderma Group AG: Promising Growth Potential and Strategic Market Positioning Drive Buy Rating
Premium
Ratings
Galderma Group AG: Promising Growth Potential and Strategic Market Positioning Drive Buy Rating
2M ago
Galderma Group AG: Strong Q3 Performance Amid Market Challenges, Hold Rating Reflects Balanced Outlook
Premium
Ratings
Galderma Group AG: Strong Q3 Performance Amid Market Challenges, Hold Rating Reflects Balanced Outlook
2M ago
Galderma Group AG: Strong Q3 Performance and Growth Potential Justify Buy Rating
Premium
Ratings
Galderma Group AG: Strong Q3 Performance and Growth Potential Justify Buy Rating
2M ago
Galderma Group AG: Buy Rating Affirmed Amid Tariff Challenges and Growth Prospects
Premium
Ratings
Galderma Group AG: Buy Rating Affirmed Amid Tariff Challenges and Growth Prospects
3M ago
More CH:GALD News >

GALD News on the Web

Galderma Group AG (GALD) Receives a Buy from UBS
TipRanks News
Neutral
Barclays Sticks to Its Buy Rating for Galderma Group AG (GALD)
TipRanks News
Neutral
Positive Report for Galderma Group AG (GALD) from UBS
TipRanks News
Neutral
Barclays Reaffirms Their Buy Rating on Galderma Group AG (GALD)
TipRanks News
Neutral
Barclays Keeps Their Buy Rating on Galderma Group AG (GALD)
TipRanks News
Neutral
Berenberg Bank Remains a Buy on Galderma Group AG (GALD)
TipRanks News
Neutral
Kepler Capital Keeps Their Buy Rating on Galderma Group AG (GALD)
TipRanks News
Neutral
Why Trump's 100% drug tariffs could hit Asia and Europe very differently
CNBC
Neutral

News Score - Last 7 Days

Neutral
CH:GALD
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CH:GALD’s Media Buzz Sentiment?
1 articles about CH:GALD were published this week. In an average week, 1 articles are published.
    What is CH:GALD’s weekly average amount of articles?
    In an average week, 1 articles about CH:GALD are published.
      What is CH:GALD’s News Sentiment?
      50% of articles about CH:GALD were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        CYTKCytokinetics
        KYTXKyverna Therapeutics, Inc.
        ANIPANI Pharmaceuticals
        DBVTDBV Technologies SA - American
        TXG10x Genomics
        Showing the stocks with the most bullish news sentiment over the past week